US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

31.99

+0.42781.36%

Volume:4K

Turnover:136.86K

Market Cap:51.94M

PE:- -

High:32.23

Open:31.63

Low:31.63

Close:31.56

52wk High:32.89

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:0.64

T/O Rate:0.26%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)

Revvity Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

How Investors Are Reacting To LifeStance Health Group (LFST) Profit Return, Guidance Hike, And New Buyback

Simply Wall St.

Mesa Labs Q1 Revenue Rises as Calibration, Biopharma Units Grow

LifeStance rises 13.2%

10x Genomics Inc : Canaccord Genuity Raises Target Price to $60 from $50

THOMSON REUTERS

XPO Names Jonas Svedlund Chief Legal Officer

10x Genomics price target raised to $47 from $42 at Piper Sandler

Thermo Fisher Eyes 15%-20% India Customer Growth on Biopharma Research, Manufacturing Boost

10x Genomics (TXG) Stock Rally Leans On Margin Gains And Cash

Simply Wall St.

Thermo Fisher CEO Marc Casper Disposes of USD 8.01 Million in Common Shares

Steris PLC Stock Outperforms Competitors on Strong Trading Day

10x Genomics is Maintained at Equal-Weight by Morgan Stanley

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and 10x Genomics (TXG)

Analysts Are Bullish on These Healthcare Stocks: Becton Dickinson (BDX), 10x Genomics (TXG)

Morgan Stanley Adjusts PT on Lifestance Health Group to $13 From $10, Maintains Overweight Rating

MT Newswires Live

10x Genomics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

10x Genomics Q2 Revenue Rises on Atera Demand

10x Genomics Q2 Swings to Loss, Revenue Falls

MT Newswires Live

Canada's WELL Health Q2 Revenue Rises, Lifts 2026 Outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/FMED/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":31.985,"timestamp":1788378926204,"preClose":31.5572,"halted":0,"volume":4289,"delay":0,"changeRate":0.013556335796585176,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Trading","change":0.4278,"latestTime":"09-02 15:56:44 EDT","open":31.63,"high":32.23,"low":31.63,"amount":136860.05995,"amplitude":0.019013,"askPrice":32.01,"askSize":500,"bidPrice":31.94,"bidSize":571,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":31.5572,"sharesOutstanding":2323806,"nav":31.741048,"aum":51541304.188688,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.54,"preClose":31.5572,"latestTime":"19:30 EDT","volume":9,"amount":284.9004,"timestamp":1788305405892,"change":-0.0172,"changeRate":-0.000545,"amplitude":0},"volumeRatio":0.640352,"impliedVol":0.0806,"impliedVolPercentile":0.2543},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.640352,"shares":1623806,"dividePrice":0,"high":32.23,"amplitude":0.019013,"preClose":31.5572,"low":31.63,"week52Low":23.48,"pbRate":"--","week52High":32.8877,"institutionHeld":0,"latestPrice":31.985,"committee":0.066293,"eps":0,"divideRate":0,"volume":4289,"delay":0,"ttmEps":0,"open":31.63,"prevYearClose":27.05,"prevWeekClose":31.6372,"prevMonthClose":31.775,"prevQuarterClose":28.525,"fiveDayClose":32.4944,"twentyDayClose":28.8396,"sixtyDayClose":24.385},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658954159","title":"Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954159?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:50","pubTimestamp":1786438213,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaV...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hims-hers-health-hims-lifestance-health-group-lfst-and-davita-dva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-hims-hers-health-hims-lifestance-health-group-lfst-and-davita-dva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMZ","DVA","HEAL","BK4559","BK4585","HIYY","LFST","BK4539","HIMS","BK4535","BK4588","FMED","GLAM","HIMY","HMYY","THNR","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658844952","title":"Revvity Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2658844952","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658844952?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:16","pubTimestamp":1786396560,"startTime":"0","endTime":"0","summary":"DJ Revvity Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  rallied 1.19% to $116.02 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.06% to 7,753.11 and Dow Jones Industrial Average  falling 0.11% to 53,975.98.This was the stock's second consecutive day of gains.Revvity Inc. closed 1.93% short of its 52-week high of $118.30, which the company achieved on January 22nd.The stock underperformed when compared to some of its competitors Monday, as Danaher Corp.  rose 2.25% to $209.37, IDEXX Laboratories Inc.  rose 1.55% to $595.76, and Agilent Technologies Inc.  rose 1.88% to $148.72.Trading volume  remained 301,209 below its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2413666426.HKD","LU0175139822.USD","IE00BQXX3D17.EUR","LU2125909593.SGD","LU0528227936.USD","LU0511384066.AUD","LU0345774391.USD","LU1721428933.USD","FMED","PAWZ","LU2404859741.USD","IE0004445239.USD","LU0320765059.SGD","LU1267930730.SGD","LU1291159041.SGD","IE00B64QTZ34.USD","LU0157215616.USD","LU0690374615.EUR","BK4082","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU0432979614.USD","LU0820561909.HKD","LU0187121727.USD","LU2089279066.USD","LU2125909247.SGD","BK4534","A","LU0347712357.USD","LU0107464264.USD","LU1941712348.USD","LU0689472784.USD","LU1366333091.USD","LU2023250504.SGD","LU2106854487.HKD","IDXX","LU0097036916.USD","LU0345774631.USD","SGXZ23171101.USD","LU1721429402.USD","LU2413666699.HKD","LU0289960550.SGD","BK4567","LU2211814178.USD","DHR","RVTY","LU1061106388.HKD","IE000M9KFDE8.USD","LU0289961442.SGD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952924","title":"How Investors Are Reacting To LifeStance Health Group (LFST) Profit Return, Guidance Hike, And New Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952924","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952924?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:25","pubTimestamp":1786393555,"startTime":"0","endTime":"0","summary":"LifeStance Health Group recently reported its second-quarter 2026 results, posting US$435.35 million in sales and returning to profitability, while also completing a buyback of 13,000,000 shares for US$97.19 million under a previously announced program and launching a new authorization of up to US$100 million in repurchases.\nAlongside raising both third-quarter and full-year 2026 revenue guidance, management pointed to clinician productivity gains, specialty service growth, and improved...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/how-investors-are-reacting-to-lifestance-health-group-lfst-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/how-investors-are-reacting-to-lifestance-health-group-lfst-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CHAT","FEBU","PMDE","BK4539","DECU","ARTY","BK4211","JOYT","BK4196","VGFPF","BK4535","ISBC","VTHR","QTOC","AIPO","LFST","RGLO","GXDW","AGIX","FMED","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959654","title":"Mesa Labs Q1 Revenue Rises as Calibration, Biopharma Units Grow","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959654","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959654?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:12","pubTimestamp":1786392774,"startTime":"0","endTime":"0","summary":"Mesa Labs Q1 revenue rises as calibration, biopharma units growOverviewUS life science tools maker's fiscal Q1 revenue rose 1.0% year-over-yearAdjusted operating income excluding unusual items increas","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470VC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTX","LU2764263039.SGD","GB00BDT5M118.USD","TMO","LU2125909916.SGD","LU1791710400.SGD","BK4534","BK4548","LU1720051108.HKD","LU1815333072.USD","LU1791710582.SGD","BK4566","BK4139","LU2125909759.SGD","QTRX","LU1989771016.USD","LU1064131342.USD","LU0266013472.USD","LU1670628061.USD","MLAB","LU2125910179.SGD","BK4121","GNMX","LU1057294990.SGD","LU1023059063.AUD","LU1923622291.USD","LU2468319806.SGD","LU2720916845.USD","LU0957791311.USD","LU1803068623.USD","LU2125909593.SGD","IE0002141913.USD","LU2092937221.SGD","LU2264538146.SGD","LU2125910336.SGD","LU2764262908.HKD","IE00B19Z8W00.USD","BK4535","LU1923621640.USD","LU2764263203.CNY","FMED","LU2089984988.USD","LU1548497426.USD","LU0557290698.USD","HRTS","LU1988902786.USD","TMED","LU2357305700.SGD","IE00B19Z9505.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658588509","title":"LifeStance rises 13.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658588509","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658588509?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:06","pubTimestamp":1786377964,"startTime":"0","endTime":"0","summary":"LifeStance (LFST) is up 13.2%, or $1.43 to $12.27. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lifestance-rises-13-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lifestance-rises-13-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFST","BK4535","BK4539","BK4196","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993450","title":"10x Genomics Inc : Canaccord Genuity Raises Target Price to $60 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993450","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993450?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:47","pubTimestamp":1786369626,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FMED","LU1861558580.USD","BK4585","LU1861559042.SGD","ARKG","BK4121","TXG","BK4588","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933024","title":"XPO Names Jonas Svedlund Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933024","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658933024?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:45","pubTimestamp":1786362327,"startTime":"0","endTime":"0","summary":"XPO names Jonas Svedlund chief legal officerXPO appointed Jonas Svedlund as chief legal officer, effective immediately.He will lead the company’s legal and compliance functions, including corporate go","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL1Xjnw2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPA","NATO","LU2125910336.SGD","LU2063271972.USD","LU2433249047.HKD","MISL","HRTS","IE00BN0W2T93.GBP","UXI","LU1093756168.USD","TMO","LU1854103824.USD","LU2125910179.SGD","LU2468319806.SGD","XPO","IE00BN0W2V16.EUR","LU2298321311.HKD","IE00BQXX3F31.USD","LU1989771016.USD","BCDF","LU1066051498.USD","LU2089984988.USD","LU1366333091.USD","XAR","IE00BN0W2W23.USD","LU0868494617.USD","IE00BJT1NW94.SGD","BK4585","EXI","IE00BQXX3C00.GBP","LU2764262908.HKD","DFEN","LU0557290698.USD","LU1066053197.SGD","LU1923621640.USD","LU1093756325.SGD","ITA","NDAQ","LU1923622291.USD","BK4232","GE","LU2211814178.USD","BK4543","TRUI","LU0823416689.USD","GNMX","LU0528227936.USD","TMED","LU1670628061.USD","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658388933","title":"10x Genomics price target raised to $47 from $42 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2658388933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658388933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:20","pubTimestamp":1786360847,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on 10x Genomics (TXG) to $47 from $42 and keeps a Neutral rating on the shares following quarterly res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/10x-genomics-price-target-raised-to-47-from-42-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/10x-genomics-price-target-raised-to-47-from-42-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1861559042.SGD","BK4588","BK4121","BK4548","ARKG","LU1861558580.USD","FMED","TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658989038","title":"Thermo Fisher Eyes 15%-20% India Customer Growth on Biopharma Research, Manufacturing Boost","url":"https://stock-news.laohu8.com/highlight/detail?id=2658989038","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658989038?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:44","pubTimestamp":1786351490,"startTime":"0","endTime":"0","summary":"UPDATE 1-Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boostHYDERABAD, Aug 10 (Reuters)-Thermo Fisher ScientificTMO.Nis eyeing a 15%-20% increase in its custome","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470EJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","IE00B2B36J28.USD","LU0208291251.USD","LU1291159041.SGD","BK4585","IE0009355771.USD","LU0096362180.USD","BK4534","IE00BJJMRZ35.SGD","LU2125909247.SGD","BK4588","LU2125910179.SGD","LU1064131342.USD","LU0320765489.SGD","BK4581","BK4566","IE00BKPKM429.USD","LU1280957306.USD","LU0957791311.USD","LU1815333072.USD","LU0122379950.USD","LU0011850046.USD","LU1720051108.HKD","TMED","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU1153585028.USD","LU0528227936.USD","LU2764262908.HKD","IE0002141913.USD","LU1712237335.SGD","IE00BQXX3D17.EUR","LU1803068623.USD","LU2543165471.USD","BK4548","IE00BQXX3C00.GBP","FMED","HRTS","LU2764263203.CNY","LU1988902786.USD","GNMX","LU2125910336.SGD","LU2125909759.SGD","TMO","LU0823416689.USD","LU0640476718.USD","IE00B19Z8W00.USD","IE00B19Z8X17.USD","LU1989771016.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657419624","title":"10x Genomics (TXG) Stock Rally Leans On Margin Gains And Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2657419624","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657419624?lang=en_us&edition=fundamental","pubTime":"2026-08-08 07:46","pubTimestamp":1786146379,"startTime":"0","endTime":"0","summary":"10x Genomics stock jumped 14.1% to about US$52 after its Q2 report, and the move appears to reflect sentiment rather than a sudden profit breakthrough. The company still reported a loss per share and quarterly revenue of US$151 million, so the market is effectively reacting to the quality of the loss, not the absence of it.\nThe key focus for traders is margin and balance sheet resilience. Gross margin improved to roughly 74%, and cash and marketable securities stood at US$552 million. Today’s...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-rally-leans-on-margin-gains-and-cash","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-rally-leans-on-margin-gains-and-cash","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1861559042.SGD","TXG","LU1861558580.USD","BK4548","FMED","ARKG","BK4585","BK4588","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657725629","title":"Thermo Fisher CEO Marc Casper Disposes of USD 8.01 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2657725629","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657725629?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:26","pubTimestamp":1786138000,"startTime":"0","endTime":"0","summary":"Thermo Fisher CEO Marc Casper disposes of USD 8.01 million in common sharesThermo Fisher Chairman and CEO Marc N. Casper exercised stock options for 10,000 shares at USD 309.63 on Aug. 5, 2026.Casper ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDLbStzZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Thermo Fisher CEO Marc Casper Disposes of USD 8.01 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0345770308.USD","TMO","LU0011850046.USD","LU1023059063.AUD","BK4588","IE00B19Z8W00.USD","LU1061106388.HKD","LU2468319806.SGD","LU1633808545.USD","LU0882574055.USD","FMED","LU1548497426.USD","LU2211815571.USD","LU2112291526.USD","IE00B19Z8X17.USD","IE00BJT1NW94.SGD","IE00BQXX3F31.USD","LU2543165471.USD","LU1280957306.USD","LU0345770993.USD","GB00BDT5M118.USD","LU1791710582.SGD","LU1670628061.USD","LU0316494557.USD","LU2764262908.HKD","LU2063271972.USD","LU2720916845.USD","BK4121","HRTS","LU0114720955.EUR","BK4548","LU0640476718.USD","IE00BQXX3D17.EUR","LU0823416689.USD","LU1057294990.SGD","LU2211814178.USD","BK4535","LU2764263203.CNY","TMED","IE00B4R5TH58.HKD","GNMX","LU0234572021.USD","LU0320765489.SGD","LU1854104046.USD","BK4581","LU2089984988.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657291556","title":"Steris PLC Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2657291556","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657291556?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:05","pubTimestamp":1786136700,"startTime":"0","endTime":"0","summary":"DJ Steris PLC Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Steris PLC  rallied 2.45% to $237.47 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.62% to 7,757.64 and the Dow Jones Industrial Average  rising 0.28% to 54,036.93.The stock's rise snapped a two-day losing streak.Steris PLC closed 11.87% short of its 52-week high of $269.44, which the company achieved on January 16th.The stock outperformed some of its competitors Friday, as Thermo Fisher Scientific Inc.  rose 2.41% to $594.00, Danaher Corp.  rose 2.39% to $204.76, and Becton Dickinson & Co.  fell 0.12% to $176.86.Trading volume  remained 18,525 below its 50-day average volume of 820,294.Data source: Dow Jones Market Data, FactSet. Data compiled August 7, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMO","SG9999013999.USD","IHI","LU1989771016.USD","SGXZ57979304.SGD","LU0107464264.USD","DHR","LU0162691827.USD","LU0342679015.USD","LU0708995401.HKD","HRTS","LU0109391861.USD","SG9999001176.SGD","GB00BDT5M118.USD","IE00BZ1G4Q59.USD","LU2720916845.USD","LU2355687059.USD","LU0672654240.SGD","STE","IE00BQXX3C00.GBP","LU0820562030.AUD","LU1059921491.USD","LU0320765489.SGD","LU2265009873.SGD","LU0114720955.EUR","LU0320765059.SGD","LU2244417387.USD","LU0820561818.USD","LU0312595415.SGD","GNMX","LU2112291526.USD","LU2360108059.USD","TMED","BK4588","BDX","LU0345770993.USD","LU1571399168.USD","BK4548","LU1670628061.USD","LU0689472784.USD","LU0289739343.SGD","LU1150488135.SGD","LU0068578508.USD","LU0985489474.SGD","LU0011850046.USD","LU1720051108.HKD","LU0878866978.SGD","LU0130518102.USD","FMED","LU2125909759.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657862380","title":"10x Genomics is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2657862380","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657862380?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:27","pubTimestamp":1786127220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TXG/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4548","FMED","BK4585","LU1861558580.USD","BK4588","ARKG","TXG","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657362873","title":"Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and 10x Genomics (TXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657362873","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657362873?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:00","pubTimestamp":1786125646,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Verrica Pharmaceuticals (VRCA) and 10x Genomics (TXG). Verrica Ph...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0128526141.USD","LABU","BK4007","ARKG","BK4137","BK4581","FMED","BK4548","TXG","LU1861559042.SGD","VRCA","HCSG","LU1861558580.USD","XBI","BK4585","LU0029874061.USD","BK4121","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657646498","title":"Analysts Are Bullish on These Healthcare Stocks: Becton Dickinson (BDX), 10x Genomics (TXG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657646498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657646498?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:00","pubTimestamp":1786107618,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Becton Dickinson (BDX), 10x Genomics (TXG) and Steri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-becton-dickinson-bdx-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-becton-dickinson-bdx-10x-genomics-txg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0130518102.USD","LU0878866978.SGD","BK4585","LU0985489474.SGD","BK4588","LU0162691827.USD","LU1571399168.USD","BK4082","BK4504","LU0985320562.USD","LU0648000940.SGD","BK4121","LU1861558580.USD","IHI","LU0072461881.USD","BDX","LU1150488135.SGD","LU0477156797.USD","LU1894683264.USD","ARKG","LU0130103400.USD","IE00BFXG1179.USD","LU1854104046.USD","LU1489326972.SGD","LU0433182093.SGD","LU1201861165.SGD","LU0068578508.USD","FMED","LU0511384066.AUD","LU1059921491.USD","LU1861559042.SGD","LU0006061336.USD","LU0266013472.USD","LU0289961442.SGD","LU0289739343.SGD","BK4548","LU1854103824.USD","TXG","LU1150488218.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657611338","title":"Morgan Stanley Adjusts PT on Lifestance Health Group to $13 From $10, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657611338","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657611338?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:29","pubTimestamp":1786094994,"startTime":"0","endTime":"0","summary":"Lifestance Health Group (LFST) has an average rating of buy and mean price target of $12.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FMED","LFST","BK4196","BK4539","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657775663","title":"10x Genomics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657775663","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657775663?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:01","pubTimestamp":1786050098,"startTime":"0","endTime":"0","summary":"10x Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary10x Genomics, Inc.TXG.OQreported a quarterly adjusted loss of 14 cents per share for the quarter ended June 30, lower","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4588","BK4585","FMED","BK4121","TXG","ARKG","LU1861559042.SGD","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650213","title":"10x Genomics Q2 Revenue Rises on Atera Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650213","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650213?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:22","pubTimestamp":1786047738,"startTime":"0","endTime":"0","summary":"10x Genomics Q2 revenue rises on Atera demandOverviewUS life science tools firm's Q2 revenue rose 3% yr/yr, beating analyst expectationsCompany posted Q2 net loss as operating expenses rose on lower s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","PACB","BK4121","ARKG","BK4585","LU1861559042.SGD","TXG","BK4588","CTKB","FMED","LU1861558580.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657668345","title":"10x Genomics Q2 Swings to Loss, Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2657668345","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657668345?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:19","pubTimestamp":1786047548,"startTime":"0","endTime":"0","summary":"10x Genomics  reported a Q2 loss late Thursday of $0.14 per diluted share, swinging from earnings of $0.28 a year earlier.Analysts polled by FactSet expected a loss of $0.24.Revenue for the quarter ended June 30 was $151.0 million, down from $172.9 million a year earlier.Analysts expected $146.7 million.For full-year 2026, the company now expects revenue of $610 million to $630 million, up from its prior guidance of $600 million to $625 million. Analysts expect $613.7 million.Shares of 10x Genomics were down nearly 3% in after-hours activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4121","ARKG","BK4585","LU1861559042.SGD","TXG","BK4588","FMED","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657657748","title":"Canada's WELL Health Q2 Revenue Rises, Lifts 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657657748","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657657748?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:10","pubTimestamp":1786047011,"startTime":"0","endTime":"0","summary":"Canada's WELL Health Q2 revenue rises, lifts 2026 outlookOverviewCanada digital healthcare firm's Q2-2026 revenue rose 12% yr/yr, driven by Canadian Patient ServicesAdjusted EBITDA fell 3% due to prio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRVA","BK4196","FMED","LFST","BK4581","BK4539","BK4535"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}